The human body at cellular resolution: the NIH Human Biomolecular Atlas Program.
HuBMAP Consortium. · 2019
Read The human body at cellular resolution: the NIH Human Biomolecular Atlas Program. by HuBMAP Consortium. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6800388.txt.
Introduction
HuBMAP Consortium describe the NIH Human Biomolecular Atlas Program, an effort to map the human body at cellular resolution. New technologies can chart tissues in three dimensions with fine molecular detail. Over seven years, HuBMAP aims to build an accessible framework for single-cell mapping. It will support technology development, data collection, and spatial mapping across organs.
Trillions of cells in many states make up the body, yet their detailed organization in tissues is largely unmapped. HuBMAP will register single-cell profiles onto tissue images. Protein location, cell type markers, and neighborhood states will be layered in. The program coordinates with other agencies and consortia toward one shared atlas. The goal is a reference for health and disease alike.
Catalog record
| CREATOR | HuBMAP Consortium. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The human body at cellular resolution: the NIH Human Biomolecular Atlas Program Published in: Nature DOI: 10.1038/s41586-019-1629-x ABSTRACT Transformative technologies are enabling the construction of three-dimensional maps of tissues with unprecedented spatial and molecular resolution. Over the next seven years, the NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) intends to develop a widely accessible framework for comprehensively mapping the human body at single-cell resolution by supporting technology development, data acquisition, and detailed spatial mapping. HuBMAP will integrate its efforts with other funding agencies, programs, consortia, and the biomedical research community at large towards the shared vision of a comprehensive, accessible three-dimensional molecular and cellular atlas of the human body, in health and under various disease conditions. MAIN The human body is an incredible machine. Trillions of cells, organized across an array of spatial scales and a multitude of functional states, contribute to a symphony of physiology. While we broadly know how cells are organized in most tissues, a comprehensive understanding of the cellular and molecular states and interactive networks resident in the tissues and organs, from organizational and functional perspectives, is lacking. The specific three-dimensional organization of different cell types, together with the effects of cell–cell and cell–matrix interactions in their natural milieu, have a profound impact on normal function, natural ageing, tissue remodelling, and disease progression in different tissues and organs. Recently, new technologies have enabled the molecular characterization of a multitude of cell types1–4 and mapping of their spatial relationships in complex tissues at unprecedented scale and single-cell resolution. These advances create the opportunity to build a high-resolution atlas of three-dimensional maps of human tissues and organs. HuBMAP (https://commonfund.nih.gov/hubmap) is an NIH-sponsored program with the goals of developing an open framework and technologies for mapping the human body at cellular resolution as well as generating foundational maps for several tissues obtained from normal individuals across a wide range of ages. A previous NIH-sponsored project, GTEx5, examined DNA variants and bulk tissue expression patterns across approximately a thousand individuals, but HuBMAP is a distinct project focused on generating molecular maps that are spatially resolved at the single-cell level but using samples from a more limited number of people. To achieve these goals, HuBMAP has been designed as a cohesive and collaborative organization, with a culture of openness and sharing using team science-based approaches6. The HuBMAP Consortium (https://hubmapconsortium.org/) will actively work with other ongoing initiatives including the Human Cell Atlas7, Human Protein Atlas8, LIfeTime (https://lifetime-fetflagship.eu/), and related NIH-funded consortia that are mapping specific organs (including the brain9, lungs (https://www.lungmap.net/), kidney (https://kpmp.org/about-kpmp/), and genitourinary (https://www.gudmap.org/) regions) and tissues (especially pre-cancer and tumours10; https://humantumoratlas.org), as well as other emerging programs. HUBMAP ORGANIZATION AND APPROACHES The HuBMAP consortium comprises members with diverse expertise (for example, molecular, cellular, developmental, and computational biologists, measurement experts, clinicians, pathologists, anatomists, biomedical and software engineers, and computer and data information scientists) and is organized into three components: (1) tissue mapping centres (TMCs); (2) HuBMAP integration, visualization and engagement (HIVE) collaborative components; and (3) innovative technologies groups (transformative technology development (TTD) and rapid technology implementation (RTI)) (Fig. 1). Throughout the program, HuBMAP will increase the range of tissues and technologies studied through a series of funding opportunities that have been designed to be synergistic with other NIH-funded and international efforts. In the later stages of HuBMAP, demonstration projects will be added to show the utility of the generated resources and, importantly, to engage the wider research community to analyse HuBMAP data alongside data from other programs or their own labs.Fig. 1The HubMAP consortium.The TMCs will collect tissue samples and generate spatially resolved, single-cell data. Groups involved in TTD and RTI initiatives will develop emerging and more developed technologies, respectively; in later years, these will be implemented at scale. Data from all groups will be rendered useable for the biomedical community by the HuBMAP integration, visualization and engagement (HIVE) teams. The groups will collaborate closely to iteratively refine the atlas as it is gradually realized. TISSUE AND DATA GENERATION The HuBMAP TMCs will collect and analyse a broad range of largely normal tissues, representing both sexes, different ethnicities and a variety of ages across the adult lifespan. These tissues (Fig. 2) include: (1) discrete, complex organs (kidney, ureter, bladder, lung, breast, small intestine and colon); (2) distributed organ systems (vasculature); and (3) systems comprising dynamic or motile cell types with distinct microenvironments (lymphatic organs: spleen, thymus, and lymph nodes). Tissue will be collected at precisely defined anatomical locations (when possible, photographically recorded) according to established protocols that preserve tissue quality and minimize degradation. Beyond meeting standard regulatory requirements, to the greatest extent possible, consent will be obtained so that the generated data is available for open-access data sharing (that is, public access without approval by data committees), to maximize their usage by the biomedical community.Fig. 2Key tissues and organs initially analysed by the consortium.Using innovative, production-grade (‘shovel ready’) technologies, HuBMAP TMCs will generate data for single-cell, three-dimensional maps of various human tissues. In parallel, TTD projects (and later RTI projects) will refine assays and analysis tools on a largely distinct set of human tissues. Samples from individuals of both sexes and different ages will be studied. The range of tissues will be expanded throughout the program. To achieve spatially resolved, single-cell maps, the TMCs will use a complementary, iterative, two-step approach (Fig. 3). First, ’omic assays, which are extremely efficient for data acquisition, will be used to generate global genome sequence and gene expression profiles of dissociated single cells or nuclei in a massively parallel manner. The molecular state of each cell will be revealed by single-cell transcriptomic11 and, in many cases, chromatin accessibility12,13 assays; imputation of transcription factor binding regions from the open chromatin data combined with the gene expression data will be used to explain the regulation of gene expression across the distinct cell types14. Second, spatial information (abundance, identities, and localization) will be acquired for various biomolecules (RNA15, protein16, metabolites, and lipids) in tissue sections or blocks, using imaging methodologies such as fluorescent microscopy (confocal, multiphoton, lightsheet, and expansion), sequential fluorescence in situ hybridization (seqFISH)17,18, imaging mass spectrometry19,20, and imaging mass cytometry (IMC)21–24. The extensive single-cell and nucleus profiles obtained will inform in situ modalities (for example, single-cell or nucleus RNA sequencing will be used to choose probes for RNA or proteins), which will provide spatial information for up to hundreds of molecular targets of interest. These data will allow the computational registration of cell-specific epigenomic or transcriptomic profiles to cells on a histological slide to reveal various microenvironmental states. They will potentially include information about protein localization to cytoplasm, nucleus, or cell surface; phosphorylation; complex assembly; extracellular environment; and cellular phenotype determined by protein marker coexpression. Registration and computational integration of complex imaging data will provide biological insights beyond any single imaging mode19,25. The powerful combination of single-cell profiling and multiplexed in situ imaging will provide a pipeline for constructing multi-omics spatial maps for the various human organs and their cellular interactions at a molecular level.Fig. 3Map generation and assembly across cellular and spatial scales.HuBMAP aims to produce an atlas in which users can refer to a histological slide from a specific part of an organ and, in any given cell, understand its contents on